Delamanid-d4

• Description:

  Delamanid-d4 is the deuterium labeled Delamanid. Delamanid, a newer?mycobacterial cell wall synthesis ?inhibitor, inhibits the synthesisi of mucolic acids[1].

• Product Name Alternative:

  OPC-67683-d4

• UNSPSC:

  12352005

• Target:

  Bacterial

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Purity:

  98.44

• Solubility:

  DMF : ≥ 25mg/mL|DMSO : ≥ 20mg/mL

• Smiles:

  FC (F) (F) OC1=CC=C (OC2CCN (C3=C ([2H]) C ([2H]) =C (OC[C@@]4 (C) CN5C (O4) =NC ([N+] ([O-]) =O) =C5) C ([2H]) =C3[2H]) CC2) C=C1

• Molecular Formula:

  C25H21D4F3N4O6

• Molecular Weight:

  538.51

• References & Citations:

  [1]Sotgiu G, et al. Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis. Expert Rev Anti Infect Ther. 2015 Mar;13 (3) :305-15.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported